<DOC>
	<DOCNO>NCT02744872</DOCNO>
	<brief_summary>Lung transplant patient experience mark decrease renal function post transplant mainly due cyclosporine induce renal change . Calcium channel blocker may improve renal function cyclosporine treat transplant recipient effect avoid cyclosporine-induced renal vasoconstriction facilitate renal sodium output . The aim study examine calcium channel blockade administer lung transplantation prevent cyclosporine induce nephropathy . The design intention treat randomize double blind single center study . Patients randomize two group , one receive felodipine one receive placebo . Study population patient list lung transplantation Denmark study period . Intervention tablet felodipine titrate 10 mg , one daily dose 12 week Primary endpoint change renal function measure glomerular filtration rate use chromium-51 label ethylenediamine tetraacetic acid ( 51-Cr-EDTA ) felodipine treat group compare placebo group .</brief_summary>
	<brief_title>Copenhagen Acute Renal Complications After Transplantations Study Group</brief_title>
	<detailed_description>Lung transplant patient experience mark decrease renal function post transplant mainly due cyclosporine induce renal change . Calcium channel blocker exert renal effect consist mainly renal vasodilation facilitation renal excretion sodium direct action renal tubule . Calcium channel blocker improve renal function cyclosporine treat transplant recipient effect avoid cyclosporine-induced renal vasoconstriction facilitate renal sodium output . Studies animal model human demonstrate calcium channel blocker maintain reduce renal vascular resistance preserve enhance renal blood flow glomerular filtration rate ( GFR ) . The aim study examine calcium channel blockade administer lung transplantation prevent cyclosporine induce nephropathy . The design intention treat randomize double blind single center study . Patients randomize two group , one receive felodipine one receive placebo . Study population patient list lung transplantation Denmark study period . Sample size calculation estimate 32 patient need , 16 patient group , estimate dropout incidence 5 patient group . This able detect estimate 50 % reduction decrease measure GFR 40 ml/min placebo group 20 ml/min treatment group , 80 % power two-sided t-test , 5 % significance level . Intervention tablet Felodipine titrate 10 mg , one daily dose 12 week Renal function determine 51-Cr-EDTA clearance measurement time 0 transplantation 1 , 3 12 week . Primary endpoint change renal function measure 51-Cr-EDTA clearance felodipine treat group compare placebo group . Safety monitor adverse event usually mild headache , tachycardia , leg edema , angina pectoris hypotension .</detailed_description>
	<mesh_term>Felodipine</mesh_term>
	<criteria>All patient undergo lung transplantation Denmark Fertile woman use contraceptive Patients allergic calcium antagonists Patients receive treatment Calcium antagonist 14 day prior transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>lung transplantation</keyword>
	<keyword>chronic renal insufficiency</keyword>
</DOC>